We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Bitter medicine

26 January 2009 By Robert Cyran

The takeover is being greased by $22.5bn in loans from a bank consortium that looks like a Who s Who of Tarp recipients. Using taxpayer money to fund Pfizer s corporate bloodletting will raise uncomfortable questions in Washington.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)